AbbVie
ABBV
#25
Rank
HK$4.063 T
Marketcap
HK$2,299
Share price
0.63%
Change (1 day)
35.15%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2026 (TTM): HK$68.00 Billion

According to AbbVie's latest financial reports the company's current earnings are HK$64.38 Billion. In 2025 the company made an earning of HK$51.72 Billion, an increase over its 2024 earnings that were of HK$29.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) HK$68.00 B31.47%
2025 HK$51.72 B77.53%
2024 HK$29.13 B-40.54%
2023 HK$49.00 B-53.62%
2022 HK$105.67 B3.76%
2021 HK$101.85 B282.25%
2020 HK$26.64 B-59.67%
2019 HK$66.07 B62.13%
2018 HK$40.75 B-32.74%
2017 HK$60.59 B-1.99%
2016 HK$61.82 B18.65%
2015 HK$52.10 B180.5%
2014 HK$18.57 B-55.57%
2013 HK$41.81 B-6.86%
2012 HK$44.89 B56.05%
2011 HK$28.76 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
HK$54.16 B-20.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$272.63 B 299.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$80.66 B 18.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$7.93 B-88.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-HK$15.33 Billion-122.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$88.85 B 30.27%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$112.38 B 64.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$56.10 B-17.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
HK$6.41 B-90.59%๐Ÿ‡บ๐Ÿ‡ธ USA